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Deep brain stimulation (DBS) has been used to modulate aberrant circuits associated
with Parkinson’s disease (PD) for decades and has shown robust therapeutic benefits.
However, the mechanism of action of DBS remains incompletely understood. With
technological advances, there is an emerging use of functional magnetic resonance
imaging (fMRI) after DBS implantation to explore the effects of stimulation on brain
networks in PD. This systematic review was designed following the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to summarize
peer-reviewed articles published within the past 10 years in which fMRI was employed
on patients with PD-DBS. Search in PubMed database provided 353 references, and
screenings resulted in a total of 19 studies for qualitative synthesis regarding study
designs (fMRI scan timepoints and paradigm), methodology, and PD subtypes. This
review concluded that fMRI may be used in patients with PD-DBS after proper safety
test; resting-state and block-based fMRI designs have been employed to explore
the effects of DBS on brain networks and the mechanism of action of the DBS,
respectively. With further validation of safety use of fMRI and advances in imaging
techniques, fMRI may play an increasingly important role in better understanding of the
mechanism of stimulation as well as in improving clinical care to provide subject-specific
neuromodulation treatments.
Keywords: Parkinson’s disease, functional connectivity, DBS, deep brain stimulation, fMRI, functional MRI,
neuroimaging

INTRODUCTION
Deep brain stimulation (DBS) is a well-established neurosurgical treatment for Parkinson’s disease
(PD) that works by modulating aberrant neural circuits via electrical stimulation to a key structure,
most commonly the subthalamic nucleus (STN) or globus pallidus internus (GPi) (1). DBS has
shown both rapid and sustained improvements of PD motor symptoms (1, 2). The effects of
DBS on non-motor symptoms have been described, such as PD-related pain (3) and cognitive
functions (4), although the efficacy is still controversial (5, 6). Individual PD patients may respond
to DBS differently (7) and the underlying therapeutic mechanism of stimulation action remains
incompletely understood (1, 2). This is partially due to the complexity of neural circuits, electrical
stimulation affecting both locally and globally, the innumerous possible combination of parameters
for DBS programming, and the inter-individual variability (1, 2, 8).
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numbers of participants and subjects’ states during scanning,
fMRI paradigms, timepoints of fMRI acquisition, and analysis
methods. Customized table formats were used to group articles
and explore possible heterogeneity. Meta-analysis was not
performed, as the purpose of this review is to provide qualitative
rather than quantitative evaluations.

Studies have utilized multiple neuroimaging techniques
to investigate the modulatory effects of DBS on brain
activity, including non-invasive methods, such as positron
emission tomography (PET), single-photon emission computed
tomography (SPECT), and functional magnetic resonance
imaging (fMRI) (8, 9). Compared with PET and SPECT, fMRI
provides better spatiotemporal resolution for detecting brain
activity across small but distributed areas associated with the
basal ganglia (2, 10). Moreover, fMRI can be continuously
acquired while DBS is switched on and off (11). It does
not require the use of tracers, which introduces confounding
variables between subjects due to different metabolic kinetics
(8). The challenges of using fMRI in DBS-implanted patients are
related to hardware artifact, as well as safety concerns, including
the possibilities of lead migration, heating, and DBS hardware
malfunction (2, 8); however, both 1.5 and 3 T fMRI scanning have
been shown to be feasible and safe with DBS systems both turned
OFF and ON (2, 12–14).
This will likely pave the way for additional DBS neuroimaging
studies, thereby providing a more comprehensive understanding
of the mechanism of DBS and improving clinical care for
individual patients with PD. The purpose of this systematic
review is to summarize the available literature on the use of fMRI
in PD patients who have undergone DBS treatment in terms of
important recent findings and the significance of fMRI as a highly
informative tool.

RESULTS
Article Selection
The search strategy described above yielded 353 articles.
Following the abstract and title screening, 295 articles were
excluded as they were not relevant to the use of fMRI and
PD-DBS patients that resulted in 58 articles. Full-text screening
excluded 34 articles, which led to 24 articles included for narrative
synthesis. Five articles were not comparable due to the type of
articles and purposes of their studies, and finally, 19 studies were
included for qualitative synthesis (Figure 1).
The assessment of the risk of bias (Figure 1) revealed that
5 studies had high risk of “sequence generation” due to noncounterbalanced scanning conditions of DBS settings (1, 10, 13)
or the nature of the study design (17, 18). Most of the studies did
not specify if the assessors were blinded (allocation concealment),
however, the nature of voxel-based fMRI imaging analysis (such
as, preprocessing and FDR corrected p-values lowered the risk
of bias.

Study Characteristics
The fMRI design paradigms that were used in the included
articles were categorized into three groups: (1) resting-state
fMRI (rs-fMRI), during which subjects were asked to remain
relaxed for 6–10 min (2, 4, 7, 10, 14, 19–26). (2) A DBS
ON/OFF block design, wherein stimulation was cycled ON and
OFF while the subject laid still in the scanner, to investigate
the mechanism of action of DBS (1, 2, 11, 13, 18, 27). (3)
Behavior-dependent task-based design, where a behavioral or
stimulus task was interleaved with rest while DBS was either
ON or OFF during each session (9, 17, 22, 28, 29) (Table 1).
The main approaches of fMRI data analysis used in the
reviewed studies included functional connectivity (FC), effective
connectivity (EC), eigenvector centrality mapping (ECM), and
contrast images (Table 1). In addition, these metrics were
correlated with clinical measurements, such as UPDRS-III score,
and/or imported to machine learning models. The 19 studies
included for qualitative synthesis were grouped according to
study purposes and fMRI paradigms: the mechanism of action
of DBS, the acute phase after lead implantation, the effects of
chronic stimulation, the effects of DBS on non-motor symptoms
in PD, and DBS vs. Levodopa (Table 2).

METHODS
This systematic review was performed following the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines (15) to collect scientific studies in which
fMRI was employed in PD patients who had undergone
DBS implantations. The search was performed in PubMed
database to find English-language articles published from
January 2010 to May 2021 (last searched date: June 1, 2021)
using the combination of keywords: (“function∗ ”[All Fields])
AND (“MR”[All Fields] OR “MRI”[All Fields] OR “magnetic
resonance”[All Fields]) AND (“DBS”[All Fields] OR “deep
brain stimulation”[All Fields]) AND (“parki∗ ”[All Fields]). The
resulting references were imported to Covidence.org, which
automatically removes duplicate articles. Then, the abstracts and
titles of the references were screened by two authors for relevance
to fMRI in PD-DBS patients. Full text articles were reviewed by
five reviewers working independently to screen articles that met
the inclusion criteria: human subjects with PD treated with DBS,
fMRI acquired after DBS implantation with a purpose relevant
to PD. Articles involving patients with PD as controls to study
other diseases were not included. Two reviewers resolved possible
conflicts to select articles included in this review.
The assessment of study risk of bias was carried out
following the Cochrane guidelines (Chapter 8) (16) by evaluating
each included article from the following domains: selection,
performance, detection, attrition, reporting, and other biases.
For each domain, a judgment of high-risk, low-risk, or unclear
was determined. Extracted variables from each article were
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The Mechanism of Action of DBS
Six original studies employed the DBS ON/OFF block paradigm
in their fMRI scans to investigate the immediate changes
in BOLD signals induced by stimulation ON vs. OFF at
various post-operative timepoints ranging from the same day of
patients’ lead implantation surgery (11, 27) to over 2-year postimplantation (1, 2, 13, 18). Nearly all recruited patients had DBS
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FIGURE 1 | (A) Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flowchart. (B) Review authors’ judgments about each risk of bias
domain for the 19 articles included in qualitative synthesis, following the Cochrane guidelines (high-risk in red, low-risk in green, and unclear risk of bias in yellow).

implanted in the STN, except that two studies also included a
number of GPi DBS patients and analyzed both targets as a single
group (1, 18).
Contrast images of DBS ON-OFF revealed some similar
neurocircuit responses across independent cohorts regardless of
ON/OFF block length or duration post-operation: (a) significant
activation of thalamus was observed in all of six studies, (b)
significant activation of pallidum in three studies (2, 13, 18),
(c) significant deactivation of cerebellum in two studies (1, 2),
while increased cerebellar activity found to be associated with
side effects (27), and (d) significant changes of the primary
motor cortex (M1) of which increased activation seen in
rigidity phenotypes (18, 27), whereas significant deactivation
seen in tremor-dominant phenotypes (1, 2, 13, 18). Of these
regions of interests (ROIs), two circuits were identified showing
opposite responses to DBS: the activated GPi-circuit covering the
GPi, thalamus, and deep cerebellar nuclei and the deactivated
M1-circuit covering the primary motor cortex, putamen, and
cerebellum. They were found functionally dissociable based on
the pre-operative resting state FC analysis (2).
Moreover, BOLD responses to STN DBS were demonstrated
to be correlated with motor symptom subscales and specific
clinical outcomes (2, 18, 27). The rigidity subgroup responded
with activated M1 and SMA (18), and its improvements were
significantly correlated with the higher activation in M1 (27) and
the GPi-circuit (2). The tremor-dominant subgroup responded
with deactivated M1 (18), and its improvements were associated
with the higher activation in thalamus (27). Activation in

Frontiers in Neurology | www.frontiersin.org

the cerebellar and sensorimotor cortices were correlated with
paresthesia and nausea side effects; and activation in the
caudate and putamen regions were correlated with dystonia side
effects (27). In comparison with STN stimulation, GPi DBS
induced BOLD responses were similar in the rigidity and tremor
subgroups; however, in the subgroup with postural instability
gait disorder, GPi DBS induced M1 deactivation whereas STN
stimulation resulted in the M1 activation and better clinical
improvement (18).
Using the same fMRI paradigm, three studies explored how
stimulation parameters (i.e., contact, voltage, or frequency)
affect the functional activity by assessing stimulation-induced
BOLD responses obtained under clinically optimized settings,
followed by non-optimized settings during which only one
parameter was altered (1, 2, 13). Compared with the fMRI
signatures of the optimal DBS settings (activation in the thalamus
and deactivation in M1 and anterior cerebellum), stimulation
at non-optimal contacts led to a diminished magnitude in
M1 and increased signals in non-motor cortex (1). Lowervoltage stimulation did not change the topographic pattern but
reduced the magnitude of BOLD signals; while high-voltage
stimulation produced stronger BOLD signals but accompanied
by increased activation in non-motor regions (1). The frequency
parameter significantly affected the GPi-thalamus-cerebellum
circuit, but not the M1-putamen-cerebellum circuit (2). The
optimal stimulation frequency induced the strongest activation
in the GPi-circuit, while slightly increased frequency (+30 Hz)
resulted in decreased activation in primary somatosensory cortex
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to likely counterbalance the physical disruption from electrode
penetration and microlesion. The EC in the brainstem hubs
were inversely correlated with the sub-scores of the UPDRS-III,
regardless of surgery stage (combined pre- and post-operative
DBS-OFF UPDRS-III scores). After DBS was activated, EC in
the left premotor cortex increased, and FC analysis seeded in
the brainstem hubs showed significant increased connectivity
with the cerebellum (21). These fMRI study findings indicated
that microlesion affected BOLD responses to stimulation with
a compensating activation in the brainstem, which is different
from the mechanism of action DBS described in previous section,
even though UPDRS-III scores obtained during and after the
microlesion effect were similar.

TABLE 1 | Summary of the types of functional MRI (fMRI) paradigms and analyses.
fMRI paradigm

Descriptions

Resting-state fMRI

Subjects remain relaxed for 6–10
mins, during which the DBS was
either ON or OFF

DBS ON/OFF block design

Subjects laid still while the DBS
was switched ON and OFF for
30 s in each state. This is to
mimic the conventional
task-based fMRI paradigm

Behavior-dependent task-based design

Subjects were asked to perform
a task (or receive stimulus), while
DBS was either ON or OFF
during the scan session

fMRI analysis

Descriptions

Functional connectivity (FC)

A statistical correlation of brain
activity indicating the
synchronization between regions
and/or voxels

Effective connectivity (EC)

The directional influence that a
brain region has over another
region indicating a causal
relationship between these two
regions

Eigenvector centrality mapping (ECM)

A data-driven and parameter-free
analysis technique based on
graph theory, which can detect
central hubs that are strongly
connected to a brain network

Contrast images

Differences in brain activation
during task/DBS-ON compared
to that during baseline/DBS-OFF

Effects of Chronic Stimulation on Motor
Networks
Six studies investigated the effects of chronic stimulation therapy
in patients who had received STN DBS treatment for at least 3
months, and conducted fMRI, during which each patient was
at rest with DBS either ON or OFF (10, 14, 20, 22, 24) or
was performing a voluntary movement task (22, 28). The order
of DBS ON/OFF was counterbalanced in five studies with no
mentioning of the washout time before fMRI with DBS OFF
(14, 20, 22, 24, 28); one study acquired fMRI with DBS-ON
first, then turned off the stimulation and waited until symptoms
reappeared before scanning with DBS-OFF (10).
Various analyses approaches were used. Horn et al. assessed
voxel-wise FC of the motor network within the basal gangliacerebellar-cortical circuit in two different scenarios: DBS ON
vs. DBS OFF. There was increased average connectivity within
motor network during DBS ON vs. OFF, specifically by
increasing the FC between thalamus and motor cortex while
reducing the coupling between striatal and three regions,
namely, GPe, STN, and cerebellum. Moreover, the amount
to which average connectivity increased was found to be
associated with the volume of activated motor STN (10).
Kahan et al. constructed a number of hypothetical neural
architectures using the dynamic causal models (DCMs) from
5 ROIs (M1, putamen, thalamus, cerebellum, and STN).
The DCM of best fit indicated that, at resting state, DBS
mostly affect the cortico-basal ganglia circuit by increasing
the coupling strengths of M1-putamen, thalamo-M1, and
putamen-thalamus pathway and significantly reducing the
connectivity of M1-STN, putamen-STN, and STN-thalamus
pathways, with no impacts on cerebellar connectivity (22).
Another study by Hanssen et al. used a similar approach but
with 7 ROIs (M1, SMA, PMC, PFC, putamen, thalamus, and
cerebellum). Cerebellar effective connectivity was significantly
increased comparing DBS ON vs. OFF, specifically the cerebelloputamen and prefronto-cerebellar circuits. Additionally, the
resting tremor improvement was found to be correlated with
DBS-induced increased prefronto-cerebellar interaction (20).
Kahan et al. performed the same DCM analysis on taskbased fMRI data during voluntary movement from the same
cohort and revealed a different architecture model with an
additional recruitment of cerebellar-basal ganglia interactions.

(13). Another important modulatory factor of DBS treatment
is time. Deactivation of the M1-putamen-cerebellum circuit
gradually increased over time within 12 months post-surgery
(2). This issue of timing of the postoperative MRI scan may be
able to explain the inconsistent findings of brain activity in M1
(1, 2, 11, 27).

The Acute Phase After Lead Implantation
Two studies focused on changes in brain activation associated
with the microlesion effect (MLE)—a phenomenon where
electrode implantation into the STN or GPi is associated with
motor improvement prior to the onset of stimulation (9, 21, 30,
31). The mechanism behind MLE was assessed by fMRI scanned
with DBS-OFF 0–3 days after implantation compared with preoperative fMRI data (9, 21). In movement state, via finger
tapping task-based fMRI, the amplitude of BOLD responses
was found significantly decreased in the motor cortex, insula,
thalamus, and basal ganglia, after edema scores were considered
as covariates. Besides, the improvements of rigidity and axial
UPDRS-III scores were significantly correlated with the BOLD
signals in the putamen and globus pallidus (9). In resting state,
a data-driven ECM analysis of the whole brain revealed that
the brainstem (specifically 2 clusters in the upper and lower
brainstem) acted as a compensatory hub in the motor network

Frontiers in Neurology | www.frontiersin.org
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TABLE 2 | Summary of included articles for qualitative analyses.
References

Subj # PD (HC) Target

MRI scanner

fMRI category

Major fMRI measurements timepoints and
scanning conditions

1.5 T

DBS ON/OFF
block

0-3 days
post-op

Notes *

The mechanism of action of DBS
Knight et al. (11)

10

STN

· DBS ON/OFF cycling (6 s ON and 60 s
OFF)
· 2 V, 90 microsecond, 130–180 Hz
· Awake or under general anesthesia

Gibson et al. (27)

20

STN

1.5 T

DBS ON/OFF
block

0–3 days
post-op

· DBS ON/OFF cycling (6 s ON and 60 s
OFF)
· 3 V, 90 ms, 130 Hz
· Under general anesthesia

Shen et al. (2)

14

STN

3T

DBS ON/OFF
block

1, 3, 6, 12
mos post-op

· DBS ON/OFF cycling (36 s ON and
24 s OFF)

Bilateral
stimulation

· Stimulation with low (60 Hz) or high
(120 Hz) frequency
· 60 min wash-out between fMRI
sessions
Boutet et al. (1)

39

STN
GPi (n = 4)

3T

DBS ON/OFF
block

Mean 20.5
mos post-op

· DBS 30 s ON/OFF cycling
· Left stimulation with optimal, followed
by non-optimal contact or voltage **
· Bilateral stimulation with low or high
frequency
· 15 min wash-out time only before the
first fMRI scan

Dimarzio et al. (13)

14

STN

1.5 T and 3 T

DBS ON/OFF
block

Post-op after · DBS 30 s ON/OFF cycling
DBS optimized
· Medication doses continued
· Stimulation with optimal settings
(mono- or bipolar-)

Some subjects
were scanned with
meds-ON

· Followed by altered frequency by ±
30 Hz, ± 60 Hz relative to individual’s
optimal frequency **
· <5 min between fMRI sessions
DiMarzio et al. (18)

23

STN
GPi (n = 8)

1.5T and 3T

DBS ON/OFF
block

Post-op after
DBS
optimized

· DBS 30 s ON/OFF cycling

Subjects were
scanned with
meds-ON

· Medication doses continued
· DBS with clinically optimal settings
· 5 min wash-in time before ON/OFF
cycling session
The acute phase after lead implantation
Jech et al. (9)

Holiga et al. (21)

12

13

STN

STN

1.5T

1.5T

Finger-tapping
task
Resting state

Pre-op

· Med-off and DBS-OFF

0–3 days
post-op
Pre-op

· Med-off, DBS ON and OFF

0–3 days
post-op

· Unilateral bipolar stimulation
· 2.64 ± 0.44 V, 60 microsecond,
130 Hz

The effects of chronic stimulation
Kahan et al. (28)

10

STN

1.5 T

Joystick-motion
task

>6 mos
post-op

· Med-off, DBS-ON and OFF

Kahan et al. (14)

12

STN

1.5 T

Resting state

>6 mos
post-op

· Med-off, DBS-ON and OFF

10 (56)

STN

1.5 T

Resting state

>6 mos
post-op

· Med-off, DBS-ON and OFF

11

STN

1.5 T

Resting state

>3 mos
post-op

· Med-off, DBS-ON and OFF

Saenger et al. (24)
Kahan et al. (22)

Joystick-motion
task

· Med-off, DBS-ON and OFF

(Continued)
Frontiers in Neurology | www.frontiersin.org
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TABLE 2 | Continued
References

Hanssen et al. (20)
Horn et al. (10)

Subj # PD (HC) Target

MRI scanner

fMRI category

Major fMRI measurements timepoints and
scanning conditions

26

STN

1.5 T

Resting state

3–78 mos
post-op

· Med-on, DBS-ON and OFF

20 (15)

STN

1.5 T

Resting state

>4 mos
post-op

· Med-on, DBS-ON followed by
DBS-OFF**

Notes *

· 5–15min wash-out time until
symptoms reappeared
Effects of DBS on non-motor symptoms in PD
Gratwicke et al.
(19)
Dong et al. (4)

6

NBM

1.5 T

Resting state

Post-op (after
6 weeks of
DBS/sham)

· 2-week washout period

Symptom:
dementia

23(14)

STN

1.5 T

Resting state

Pre-op

· Med-off, DBS-OFF

Symptom:
executive
functions

· Med-off, DBS-ON and OFF

Symptom: chronic
pain

>3 mos
post-op
Dimarzio et al. (17)

15

STN

1.5 T and 3 T

Pain-stimulus task

13

STN

1.5 T

Resting state

Post-op

DBS vs. Levodopa
Mueller et al. (23)

Mueller et al. (29)

32

STN

1.5 T

Finger-tapping
task

18

Pre-op

· Med-on and off

0–3 days
post-op

· Med-off, DBS-ON and OFF

Pre-op

· Med-on and off

0–3 days
post-op

· Med-off, DBS ON and OFF

*Intraoperative timepoint is post lead implantation and before the implantation of stimulator. All of the post-operative fMRI acquisition was performed while the subjects were OFF
medication, unless specified. All of the deep brain stimulation (DBS) stimulation settings during DBS-ON fMRI scan was unilateral bipolar stimulation, unless specified.
**Order of fMRI sessions were not counterbalanced.
STN, subthalamic nucleus; GPi, globus pallidus internus; NBM, nucleus basalis of Meynert.

DBS-ON and healthy controls vs. DBS-OFF and healthy
controls (10). Similarly, in terms of dynamic FC, which is
used to describe the oscillation of inter-region synchronization
throughout the scan time, therapeutic stimulation was found to
increase “phase consistency” (defined as the mean and standard
deviation (SD) of all windowed FC matrices of individual
subject) toward the ones obtained from age-matched healthy
controls (24).

Active stimulation resulted in an increased effective connectivity
of STN afferent (M1-STN and putamen-STN) pathways during
voluntary movement, whereas a reduced coupling strength
during resting state (22).
Deep brain stimulation (DBS) modulatory effects were
observed in both behavior independent and dependent statuses,
but different inter-regional connectivity was affected: when
subjects were at rest, basal ganglia pathways were modulated
without the inclusion of cerebellum, while subcortical-cerebellar
pathways were activated when subjects were performing
voluntary movement (22). However, two other studies on resting
state fMRI revealed inconsistent findings, in which cerebellar
connectivities were also modulated by therapeutic DBS, but in
the opposite directions, with one study representing increased
(20) while the other study showing decreased striatal-cerebellum
connectivity (10).
Two of the six studies recruited age-matched healthy control
subjects for comparisons with each DBS-ON and DBS-OFF
conditions, and demonstrated that therapeutic DBS helps in
rebalancing resting state brain activities toward healthy controls
on a local as well as global level (10, 24). Regarding static
FC, FC maps were estimated by seeding from the activated
motor STN to the rest of the brain from rs-fMRI acquired
with DBS ON and OFF conditions, and a healthy age-matched
control group (10). The similarity of FC maps, compared using
spatial correlation values, were significantly higher between

Frontiers in Neurology | www.frontiersin.org

Effects of DBS on Non-motor Symptoms in
PD
Three of the reviewed studies looked into the effects of DBS
with regards to non-motor symptoms in PD (e.g., chronic pain,
dementia, and executive function) using rs-fMRI (4, 19) or blockdesign task-based fMRI (4). DiMarzio et al. investigated how
STN stimulation affects pain perception in PD-DBS patients with
chronic pain relief contrasted with those without pain relief.
Brain activation corresponding to pain perception was measured
using a task-based fMRI paradigm, during which mechanical
pain stimulus alternated with resting periods while the DBS was
ON or OFF throughout the scan time. Distinct patterns of brain
activation were observed: PD patients with pain relief responded
to pain with hyperactivation in primary sensory cortex (S1) and
anterior cingulate cortex (ACC) during DBS OFF, and turning
on the stimulation reduced such activation in these two regions;
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conversely, PD patients without pain relief showed deactivation
in S1 and ACC during DBS OFF, and stimulation ON increased
the activation in the two regions (17).
Gratwicke et al. recruited PD patients with dementia and
conducted two rs-fMRI scans on each subject after receiving 6
weeks of sham and DBS treatment in the Nucleus Basalis of
Meynert (NBM), received in counterbalanced order with 2 weeks
of washout intervals. FC in the default mode network revealed
no significant differences between the NBM DBS and sham
treatments, agreeing with their clinical measurements (19). Dong
et al. studied the executive functions in PD patients, who received
at least 3 months of STN-DBS, by assessing the intrinsic FC of the
executive control network from pre- and post-operative rs-fMRI
acquired in DBS-OFF condition. Although both pre- and postoperative rs-fMRI revealed significantly decreased FC comparing
with a healthy control group, no significant differences were
found between pre- and post-states (4).

cerebellum, and changes of activation in M1 to correct the motor
symptoms (i.e., activation in rigidity whereas deactivation in
tremor phenotypes). Furthermore, when compared with agematched healthy controls, DBS seems to rebalance brain activities
at resting state toward healthy subjects. Correlations of BOLD
signals with various DBS settings and UPDRS-III subscores
demonstrate the advantages of fMRI technique to explore the
effects of stimulation between PD subtypes and individuals. The
use of fMRI in patients with PD-DBS is gradually growing and
will enhance our understandings of the mechanism of DBS in
PD with the respect of improving motor and non-motor clinical
outcomes. This section addresses how the current data could
be used in the clinical setting, such as providing patient-specific
surgical planning and identifying the optimal or new targets for
various symptoms.

Safety Concerns and Artifacts
Phantom tests conducted at multiple research centers have shown
that patients with DBS implanted may safely undergo 1.5 and
3 T MRI (2, 12, 18, 21, 28, 32, 33). As MRI environment did not
interrupt the implanted pulse generator functions, more recent
studies used the body-transmit coil for the benefits of better
signal-to-noise ratio (22). Although the imaging artifact caused
by the DBS device appears as circumferences along the DBS leads
and in the frontoparietal cortex area close to DBS wire coils,
and although larger artifact is seen in 3 T compared with 1.5 T
MRI, it is still limited to the superficial cortex and the signal loss
adjacent to the electrode contacts is acceptable (12). Additionally,
shorting scan time in 3 T MRI scanner (5.5 min compared with
8 min per scan in 1.5 T MRI scanner) seems to compensate the
higher signal-to-noise ratio, and thus pooling fMRI data from
1.5 and 3 T scanners for further analyses becomes feasible (18).
Therefore, with a priori safety testing, more recent studies have
scanned patients with PD-DBS at their clinically optimal DBS
settings, including monopolar stimulation (1, 13, 18).

DBS vs. Levodopa
Mueller et al. compared the effects of oral levodopa (L-DOPA)
and STN-DBS in individual patients with PD (i.e., withinsubject comparison) using the scores of UPDRS-III, rs-fMRI, and
finger tapping task-based fMRI—all collected in four scenarios:
pre-operative L-DOPA-OFF, pre-operative L-DOPA-ON, postoperative L-DOPA-OFF and DBS-ON, and post-operative LDOPA-OFF and DBS-OFF. The UPDRS-III scores showed
comparable improvements by L-DOPA and DBS from the
baseline of the pre-op L-DOPA-OFF scores (23, 29). However,
rs-fMRI data revealed different motor network connectivity
modulations caused by these two interventions, specifically, DBSON increased EC in the bilateral motor cortices accompanied
with the increased connectivity with the thalamus and cerebellum
compared with L-DOPA-ON (23). In a later study, finger tapping
task-based fMRI was assessed via the same study design, and
beta images during TAPPING and REST were computed for
each scan scenario. It was found that L-DOPA-ON reverted
putamen activation to increased activation during TAPPINGREST, whereas these reversed patterns of putamen and motor
cortex were not found in DBS-ON vs. OFF scenario (29).

The Mechanism of Action of DBS
It has been demonstrated that DBS achieves its clinical effects
through modulating not only the local neuronal activity
within the target region, but also larger brain networks by
propagating along related circuitries (23, 27). However, the exact
neuromodulatory mechanism of how active stimulation, and
more specifically the changes of stimulation parameters, affect
brain networks still remain unclear (1, 2). A fMRI paradigm with
DBS ON/OFF cycling was employed by multiple studies in our
systematic review to measure immediate BOLD signal changes
induced by stimulation ON vs. OFF states (1, 2, 11, 13, 18, 27).
This design was validated by a high test-retest reliability at the
subject level as well as a high inter-subject consistency within
the same group or scanning conditions (2). Variations of study
designs existed among the reviewed articles, for example, the
block lengths (ON-period ranged from 6 to 30 s, OFF-period
ranged from 60 to 30 s), post-operative durations (ranging from
the same day of the lead implantation surgery to over 2-year
post implantation), wash-in/wash-out durations (e.g., unclearly
reported, 5 min wash-in period and 60 min wash-out period), and
medication on/off. Washout time following the discontinuation

DISCUSSION
This systematic review focused on summarizing the findings of
articles published within the past 10 years in which fMRI was
employed on PD-DBS patients. A direct comparison of results
is complex due to the significant variability in fMRI design
paradigm and connectivity analyses described in the previous
section. Performing 1.5 and 3 T fMRI is safe in PD-DBS patients
with the use of MRI-compatible DBS (2, 12, 18, 21, 28, 32, 33).
The effects of DBS on functional activity and integrity can vary
depending on factors, such as duration after the implantation,
DBS programming parameters, if the scan is acquired at rest or
with movement, PD subtypes, and the conditions of medication
intake. Turning the DBS ON produces immediate modulation
of the cortico-basal ganglia-thalamo-cortical loop in PD, leading
to the increased activation in thalamus and globus pallidum
(consistent with the DeLong Model of PD), deactivation in

Frontiers in Neurology | www.frontiersin.org

7

March 2022 | Volume 13 | Article 849918

Miao et al.

Use of fMRI in PD-DBS

of STN DBS is around 30–50 min, a rapid drop of 0–80% followed
by further slow washout, which varies depending on individual
disease duration, lead location (34, 35), and patients’ maneuver
(36). The rapid alternation of stimulation ON and OFF states
(ON/OFF cycling) utilized by the studies in this review may not
fully capture the entire effects of DBS on functional activation.
Future studies should consider employing a longer wash-out
period in order to overcome this limitation. Nevertheless, the
reviewed studies reached generally consistent findings: STN DBS
has significant effects throughout the motor circuitry in PD,
preferentially the thalamus, primary motor cortex, pallidum,
and cerebellum.

significantly (38). It has been shown that up to 80% of PD
patients may receive pain relief from STN DBS with different
effects depending on the types of PD pain phenotypes (39, 40).
Yet, the mechanism behind has yet to be determined. Dimarzio
et al. demonstrated the reduction of activation in primary sensory
cortex and anterior cingulate cortex after turning DBS ON in
patients who experienced pain relief, while the opposite finding
in patients without pain relief. Although these findings do not
elucidate the entire circuitry involved, the activation status of
such areas could potentially be used for patient counseling prior
to DBS implantation, e.g., managing expectations regarding pain
reduction following DBS (17). The effects of DBS on cognitive
functions in PD patients are controversial, with previous studies
showing declined, stable, or improved cognitive functions at up
to 8-year follow-up; DBS targets (STN vs. GPi) seemed to affect
the cognitive outcomes as well (5, 6). The assessments of the
resting state FC within the executive control network showed
no significant changes in post-operative DBS OFF states from
the pre-operative baseline in PD patients who received at least
3 months STN DBS (4). Future studies evaluating the effects of
chronic therapeutic DBS on cognition should include both STN
and GPi DBS, to provide better insight on the differences between
both nuclei.

Effects of DBS on Networks
Although, the non-optimized DBS programming may lead
these studies less relevant to conclusions of the therapeutic
effects of DBS on neural networks in PD-DBS patients
(8), the findings may contain predictive information in the
matter of clinical outcomes (27). The current standard-ofcare procedure for adjusting DBS parameters is labor-intensive
and time-consuming. The complexity of this process has been
further compounded by the recent introduction of segmented
leads; this increased the possible combinations of parameter
configuration (37). Furthermore, the optimization is mostly
subjective and dependent on personal and clinical experience
rather than objective detailed algorithms to generate personalized
DBS settings. For instance, acquisition of fMRI following a
programming session could have the potential to demonstrate if
activation patterns associated with the improvement in UPDRSIII subscores occurred (such as, increased activation in thalamus
and globus pallidum, deactivation in cerebellum, and the changes
of activation in M1) with a specific set of parameters. Therefore,
neuroimaging biomarkers could assist the efficiency and accuracy
in the process of DBS programming for individual patients.
Better understanding of the mechanism of chronic stimulation
may provide quantitative neuroimaging evidence for predicting
DBS efficacy for individual patients. Of the six studies reviewed
in this category, the order of fMRI sessions with DBS ON
and OFF were counterbalanced, except for one study by Horn
et al. (10), in which 5–15 min of DBS washout was included by
waiting for the reappearance of symptoms. Consistent findings
across these studies demonstrated the main effects of STN
DBS on functional connectome at resting state: stimulation
strengthens the couplings of the direct pathway and reduces
those of the hyperdirect pathway. However, the results of how
STN DBS affects the connectivity between cerebellum and
striatum were inconsistent, which might be caused in part due
to different conditions of medication intake (on or off). Even
when two studies had their subjects continue the medication
intake throughout fMRI scans, their results were contradictory
(10, 20). Therefore, future studies with consistent fMRI scanning
designs are necessary to confirm or further explore the specific
connectivity changes between the cerebellum and the basal
ganglia following chronic therapeutic DBS.
The complete circuitry involved in non-motor symptoms
of PD remains unclear. Nevertheless, symptoms, such as pain
are common in patients with PD and affect quality of life
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LIMITATIONS AND FUTURE DIRECTIONS
In this review, we only searched in PubMed database and focused
on qualitative synthesis without meta-analysis of the studies.
Reviewing of the included articles, fMRI has major advantages
in studying PD patients following DBS implantation; however,
the scanning and processing methodology of the reviewed
studies are not uniform, which limited the generalizability
and applicability of the results. Standardized fMRI scanning
parameters (e.g., the time period of each block in fMRI
DBS ON/OFF block design) and processing pipeline would
maximize the benefits of fMRI application in PD patients.
Other limitations include safety concerns and susceptibility
artifacts which can hinder the proper assessment of FC between
brain regions.
Machine learning simulation has emerged as a possible
solution. Yan et al. (41) used the deep convolutional generative
adversarial networks (DCGAN) model to reconstruct the lost
BOLD signals in PD-DBS patients. Not only parts of the
imaging data were recovered, but also the machine-learningmodel-generated BOLD signals corresponded in time with the
original signals. The main advantage of using the DCGAN
machine learning model over an oversimplified diffusion model
is that the DCGAN is able to reconstruct FC maps specific to
individual patients. Further studies are needed to improve the
reconstructive accuracy of such models and account for brain
shift that occurs during surgery.
The location of DBS electrodes is paramount for clinical
improvement in motor function, so identifying the exact location
of the electrodes is essential for optimal clinical outcomes
(33). The most effective stimulation occurs at places that are
most strongly connected to the motor network. Therefore,
future research may involve performing fMRI scans on patients
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toward healthy subjects. The findings of significant correlations
of BOLD signals with various DBS settings and UPDRS-III
subscores further signified the advantages of fMRI technique
to explore the effects of stimulation between PD subtypes and
individuals. Overall, the use of fMRI in PD-DBS patients is
showing a growing attraction to clinicians and researchers, with
the aims to enhance our understandings of the mechanism of
DBS in PD with the respect of improving motor and non-motor
clinical outcomes, providing patient-specific surgical planning,
and identifying the optimal or new targets for various symptoms.

pre-operatively with a particular emphasis in identifying contact
points that would strongly activate the motor network as this
has been shown to result in the best clinical improvement. The
ultimate goal would be to develop an artificial intelligence (AI)
model that can use clinical data and pre-operative FC maps
to accurately identify the best location of the DBS leads and
stimulation parameters specific to each patient.

CONCLUSIONS
The recent years have witnessed major advances in fMRI use
following the DBS implantation in PD patients. Studies at
multiple research centers have provided evidence for performing
1.5 and 3 T fMRI safely in PD-DBS patients with properly
designed phantom test and the use of MRI-compatible DBS
(2, 12, 18, 32). The effects of DBS on functional activity and
integrity have shown to be different depending on a number of
factors, namely, the duration after the implantation (microlesion
effect), DBS programming parameters, the subject’s activity
while being scanned (at rest or with movement), PD subtypes,
and the conditions of medication intake. fMRI studies with
a DBS ON/OFF block paradigm have shown that immediate
modulation of the cortico-basal ganglia-thalamo-cortical loop in
PD led to significant increased activation in thalamus and globus
pallidum (consistent with the DeLong model of PD), deactivation
in cerebellum, and changes of activation in M1 to correct the
motor symptoms (i.e., activation in rigidity whereas deactivation
in tremor phenotypes). Compared with age-matched healthy
controls, DBS seems to rebalance brain activities at resting state
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subthalamic microlesion story in Parkinson’s disease: electrode insertionrelated motor improvement with relative cortico-subcortical hypoactivation
in fMRI. PLoS ONE. (2012) 7:e49056. doi: 10.1371/journal.pone.0049056
10. Horn A, Wenzel G, Irmen F, Huebl J, Li N, Neumann WJ, et al. Deep brain
stimulation induced normalization of the human functional connectome in
Parkinson’s disease. Brain. (2019) 142:3129–43. doi: 10.1093/brain/awz239
11. Knight EJ, Testini P, Min HK, Gibson WS, Gorny KR, Favazza CP,
et al. Motor and nonmotor circuitry activation induced by subthalamic
nucleus deep brain stimulation in patients with Parkinson disease:
Intraoperative functional magnetic resonance imaging for deep brain
stimulation. Mayo Clinic Proc. (2015) 90:773–85. doi: 10.1016/j.mayocp.2015.
03.022
12. Boutet A, Rashid T, Hancu I, Elias GJB, Gramer RM, Germann J, et al.
Functional MRI safety and artifacts during deep brain stimulation: experience
in 102 patients. Radiology. (2019) 293:174–83. doi: 10.1148/radiol.2019190546
13. Dimarzio M, Madhavan R, Hancu I, Fiveland E, Prusik J, Joel S, et al.
Use of functional MRI to assess effects of deep brain stimulation frequency
changes on brain activation in Parkinson Disease. Neurosurgery. (2021)
88:356–65. doi: 10.1093/neuros/nyaa397
14. Kahan J, Urner M, Moran R, Flandin G, Marreiros A, Mancini L,
et al. Resting state functional MRI in Parkinson’s disease: the impact of
deep brain stimulation on “effective” connectivity. Brain. (2014) 137:1130–
44. doi: 10.1093/brain/awu027
15. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items
for systematic reviews and meta-analyses: the PRISMA statement. J Clin
Epidemiol. (2009) 62:1006–12. doi: 10.1016/j.jclinepi.2009.06.005
16. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch
VA. Cochrane Handbook for Systematic Reviews of Interventions Version 6.2

1. Boutet A, Madhavan R, Elias GJB, Joel SE, Gramer R, Ranjan M, et al.
Predicting optimal deep brain stimulation parameters for Parkinson’s disease
using functional MRI and machine learning. Nat Commun. (2021) 12:1–
13. doi: 10.1038/s41467-021-23311-9
2. Shen L, Jiang C, Hubbard CS, Ren J, He C, Wang D, et al. Subthalamic Nucleus
Deep Brain Stimulation Modulates 2 Distinct Neurocircuits. Ann Neurol.
(2020) 88:1178–93. doi: 10.1002/ana.25906
3. Custozzo A, DiMarzio M, Pilitsis JG. Addressing Parkinson disease–related
pain with deep brain stimulation. World Neurosurg. (2020) 135:381–
2. doi: 10.1016/j.wneu.2019.12.140
4. Dong W, Qiu C, Jiang X, Shen B, Zhang L, Liu W, et al. Can the
executive control network be used to diagnose parkinson’s disease and as
an efficacy indicator of deep brain stimulation? Parkinson’s Disease. (2020)
2020. doi: 10.1155/2020/6348102
5. Limousin P, Foltynie T. Long-term outcomes of deep brain
stimulation in Parkinson disease. Nat Rev Neurol. (2019)
15:234–42. doi: 10.1038/s41582-019-0145-9
6. Williams NR, Foote KD, Okun MS. Subthalamic nucleus versus globus
pallidus internus deep brain stimulation: translating the rematch into clinical
practice. Mov Disord Clin Pract. (2014) 1:24–35. doi: 10.1002/mdc3.12004
7. Shang R, He L, Ma X, Ma Y, Li X. Connectome-based model predicts deep
brain stimulation outcome in Parkinson’s Disease. Front Comput Neurosci.
(2020) 14:1–8. doi: 10.3389/fncom.2020.571527
8. Albaugh DL, Shih YYI. Neural circuit modulation during deep brain
stimulation at the subthalamic nucleus for parkinson’s disease: What
have we learned from neuroimaging studies. Brain Connect. (2014) 4:1–
14. doi: 10.1089/brain.2013.0193

Frontiers in Neurology | www.frontiersin.org

9

March 2022 | Volume 13 | Article 849918

Miao et al.

17.

18.

19.

20.

21.

22.

23.

24.

25.

26.

27.

28.

29.

30.

31.

Use of fMRI in PD-DBS

(updated February 2021). Cochrane (2021). Available online at: www.training.
cochrane.org/handbook.
Dimarzio M, Rashid T, Hancu I, Fiveland E, Prusik J, Gillogly M,
et al. Functional MRI signature of chronic pain relief from deep brain
stimulation in Parkinson disease patients. Clin Neurosurg. (2019) 85:E1043–
9. doi: 10.1093/neuros/nyz269
DiMarzio M, Madhavan R, Joel S, Hancu I, Fiveland E, Prusik J, et al. Use
of functional magnetic resonance imaging to assess how motor phenotypes
of Parkinson’s disease respond to deep brain stimulation. Neuromodulation.
(2020) 23:515–24. doi: 10.1111/ner.13160
Gratwicke J, Zrinzo L, Kahan J, Peters A, Beigi M, Akram H, et al. Bilateral
deep brain stimulation of the nucleus basalis of meynert for Parkinson
disease dementia a randomized clinical trial. JAMA Neurol. (2018) 75:169–
78. doi: 10.1001/jamaneurol.2017.3762
Hanssen H, Steinhardt J, Münchau A, Al-Zubaidi A, Tzvi E, Heldmann M,
et al. Cerebello-striatal interaction mediates effects of subthalamic nucleus
deep brain stimulation in Parkinson’s disease. Parkinsonism Relat Disord.
(2019) 67:99–104. doi: 10.1016/j.parkreldis.2019.09.003
Holiga Š, Mueller K, Möller HE, Urgošík D, RuŽička E, Schroeter ML,
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